CSL-111

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCSL-111
Drug Alias NameCSL111 (reconstituted HDL)CSL-111
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFree radicals scavengers
TargetsFree radicals
Therapy Area/IndicationsAcute Coronary SyndromeStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCsl Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCsl Ltd
Active IndicationsN/A
Inactive IndicationsAcute Coronary SyndromeStroke

Other Information

ATC CodeN/A
Related LinksN/A